Skip to content
10-K

Annual Report

GlobeStar Therapeutics Corp

0001161697-23-000049

← back to feed
Filed
Jan 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Jan 3, 2023 770.36M sh
Stock Issued FY 2022 · Feb 28, 2022 6M sh
Operating Cash Flow FY 2022 · Sep 30, 2021 −$751.23K
Cash And Equivalents FY 2022 · Sep 30, 2021 $5.96K
Cash And Equivalents FY 2022 · Sep 30, 2020 $81.44K
Current Liabilities FY 2022 · Sep 30, 2021 $731.78K
Total Liabilities FY 2022 · Sep 30, 2021 $731.78K
Current Assets FY 2022 · Sep 30, 2021 $5.96K
Total Assets FY 2022 · Sep 30, 2021 $5.96K
Rd Expense FY 2022 · Sep 30, 2021 $0
Net Income FY 2022 · Sep 30, 2021 −$9.8M
Operating Income FY 2022 · Sep 30, 2021 −$9.09M
Gross Profit FY 2022 · Sep 30, 2021 −$2.41K
Cost Of Revenue FY 2022 · Sep 30, 2021 $2.41K
Stockholders Equity FY 2022 · Sep 30, 2020 −$659.22K